Nonetheless, univariate analysis clearly illustrated the prognostic value of ICAM-1 for MSS in NRAS/BRAF melanoma (Fig. 5), where reduced expression is associated with worst survival, a finding that has not been widely reported in melanoma. This evidence concerns the gene BRAF and melanoma.